The angiotensin II type 2 receptor in renal disease

Suppression of angiotensin II formation by angiotensin-converting enzyme inhibitors or blockade of the angiotensin II receptor by angiotensin receptor blockers is a powerful therapeutic strategy to slow the progression of renal disease. However, angiotensin-converting enzyme inhibitors and angiotens...

Full description

Bibliographic Details
Main Authors: Ulrich Otto Wenzel, Christian Krebs, Ralf Benndorf
Format: Article
Language:English
Published: SAGE Publications 2010-03-01
Series:Journal of the Renin-Angiotensin-Aldosterone System
Online Access:https://doi.org/10.1177/1470320309347787